Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Reference9 articles.
1. World Health Organization (2004) http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html .WHO, Geneva
2. Natoli JL, Manack A, Dean B et al (2009) Global prevalence of chronic migraine: systematic review. Cephalalgia. doi: 10.1111/j.1468-2982.2009.01941
3. Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12(s1):59–62
4. Dodick DW, Turkel CC, DeGryse RE, et al, on behalf of the PREEMPT Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 50:921–936
5. Gillard PJ, Devine B, Varon SF, Sean LL, Sullivan D (2012) Mapping from disease-specific measures to health-state utility values in individuals with migraine. Value Health 15(3):485–494
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献